Assessing the Effect of a Long-Acting GLP-1 Agonist on Onset of Puberty in Rats

被引：0
|
作者：
Thompson, K. E. [1 ]
Buss, N. [2 ]
Stewart, J. [3 ]
机构：
[1] Bristol Myers Squibb Co, New Brunswick, NJ USA
[2] Medimmune, Gaithersburg, MD USA
[3] AstraZeneca, Macclesfield, Cheshire, England
来源：
BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY | 2015年 / 103卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q [生物科学];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
W13
引用
收藏
页码：373 / 373
页数：1
相关论文
共 50 条
  • [1] Design of a novel long-acting dual GLP-1/GIP receptor agonist
    Dong, Yuanzhen
    Zhang, Jinhua
    Xu, Hongjiang
    Shen, Hengqiao
    Lu, Qin
    Feng, Jun
    Cai, Zhengyan
    BIOORGANIC & MEDICINAL CHEMISTRY, 2024, 100
  • [2] Cardiovascular Protection with a Long-Acting GLP-1 Receptor Agonist Liraglutide: An Experimental Update
    Vandemark, Collin
    Nguyen, Jimmy
    Zhao, Zhi-Qing
    MOLECULES, 2023, 28 (03):
  • [3] Effect of the long-acting GLP-1 derivative NN2211 in 60% pancreatectomized rats
    Romer, J
    Pedersen, KE
    Jorgensen, B
    Rothe, P
    Bentsen, E
    Damgaard, N
    Knudsen, LB
    Wassermann, K
    Ribel, U
    DIABETES, 2001, 50 : A312 - A312
  • [4] Effect of the long-acting GLP-1 derivative NN2211 in 60% pancreatectomized rats
    Romer, J
    Bentsen, E
    Damgaard, J
    Jorgensen, B
    Pedersen, KE
    Rothe, P
    Knudsen, LB
    Wassermann, K
    Ribel, U
    DIABETOLOGIA, 2001, 44 : A197 - A197
  • [5] Long-acting GLP-1: Formulation and in vitro evaluation
    Castillo, Gerardo
    Reichstetter, Sandra
    Bogdanov, Alexei
    Bolotin, Elijah
    DIABETES, 2007, 56 : A127 - A127
  • [6] Expression and Characterization of a Potent Long-Acting GLP-1 Receptor Agonist, GLP-1-IgG2σ-Fc
    Yang, Yi
    Chen, Fang
    Wan, Deyou
    Liu, Yunhui
    Yang, Li
    Feng, Hongru
    Cui, Xinling
    Gao, Xin
    Song, Haifeng
    PLOS ONE, 2016, 11 (05):
  • [7] Novel GLP-1 Fusion Chimera as Potent Long Acting GLP-1 Receptor Agonist
    Wang, Qinghua
    Chen, Kui
    Liu, Rui
    Zhao, Fang
    Gupta, Sandeep
    Zhang, Nina
    Prud'homme, Gerald J.
    PLOS ONE, 2010, 5 (09): : 1 - 9
  • [8] Chronic Toxicity and Carcinogenicity Studies of the Long-Acting GLP-1 Receptor Agonist Dulaglutide in Rodents
    Byrd, Richard A.
    Sorden, Steven D.
    Ryan, Thomas
    Pienkowski, Thomas
    LaRock, Richard
    Quander, Ricardo
    Wijsman, John A.
    Smith, Holly W.
    Blackbourne, Jamie L.
    Rosol, Thomas J.
    Long, Gerald G.
    Martin, Jennifer A.
    Vahle, John L.
    ENDOCRINOLOGY, 2015, 156 (07) : 2417 - 2428
  • [9] The Novel Dual GIP and GLP-1 Receptor Agonist Tirzepatide Transiently Delays Gastric Emptying Similarly to a Selective Long-Acting GLP-1 Receptor Agonist
    Urva, Shweta
    Nauck, Michael A.
    Coskun, Tamer
    Cui, Xuewei
    Haupt, Axel
    Benson, Charles
    Loghin, Corina
    DIABETES, 2019, 68
  • [10] The novel dual GIP and GLP-1 receptor agonist, tirzepatide, transiently delays gastric emptying similarly to a selective long-acting GLP-1 receptor agonist
    Urva, S.
    Nauck, M. A.
    Coskun, T.
    Cui, X.
    Haupt, A.
    Benson, C. T.
    Loghin, C.
    DIABETOLOGIA, 2019, 62 : S58 - S58
12345